Synergy of polymyxin B and minocycline against KPC-3- and OXA-48-producing Klebsiella pneumoniae in dynamic time-kill experiments: agreement with in silico predictions.

Publication Year: 2024

DOI:
10.1093/jac/dkad394

PMCID:
PMC10832586

PMID:
38158772

Journal Information

Full Title: J Antimicrob Chemother

Abbreviation: J Antimicrob Chemother

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"raw data from sequencing are deposited in the ncbi sequence read archive under bioproject accession numbers prjna947381 (aru705) and prjna957334 (aru613)."

Code Sharing
Evidence found in paper:

"Transparency declarations: All authors declare no conflicts of interest.: Author contributionsA.O., C.Z., T.T., P.L., L.E.F. and E.I.N. conceptualized and designed the study. C.M. improved the dynamic model and A.O. performed the in vitro experiments. C.Z. performed in silico predictions and calculations on dosing in the dynamic model, under the supervision of E.I.N. and L.E.F. A.O., C.Z., T.T., P.L., L.E.F. and E.I.N. analysed and interpreted the data. A.O., C.Z., T.T. and P.L. drafted the manuscript. All authors contributed to the revision and have approved the final version of the manuscript."

Evidence found in paper:

"Funding This study was funded by the Swedish Research Council (grant no. 2019-05911 and 2020-02320 to T.T., grant no. 2018-03296 to L.E.F.), and Vinnova (grant no. 2021-02699 to T.T.)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025